PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES

PharmaTher highlights its M3DICINES™ 3D-printed medicines platform, which it says supports proprietary products, CraftMake™ placements, and partner services. Those services include CDMO work, white-label products, formulation licensing, and clinical-trial supply; the text provides no financial or operating metrics.